Industry reports
Editor highlights

Drug & Medication

Summary

Table of Contents

Data Series

  • Publication date: November 2013
  • Report size: 106 pages
Keywords : nasal spray, Drug, Fluticasone propionate, Budesonide, Salmeterol, Respiratory drug, Levalbuterol, Formoterol Fumarate, Azelastine, Xopenex, Ipratropium Bromide, Flonase, beclomethasone

Around three quarters of the US$36.4 billion respiratory prescription drugs market comprises drugs that are delivered using inhalation or nasal spray technologies. The top five drugs used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) attracted combined revenues of around US$18.0 billion in 2012. All five are blockbuster drugs. The current market leader overall is GlaxoSmithKline’s Seretide/Advair (fluticasone propi...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Drug And Medication Industry in the United States : Latest Reports

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of ...

Global Veterinary Vaccines Industry

February 2014 $ 4 950

Drug And Medication Industry in the United States : Latest Downloads

Drug and Medication Market Brief

  • Industry report
  • March 2014
  • 17 pages

... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...

World Vaccine Business Overview

  • Industry report
  • March 2014
  • 22 pages
  • by Intergovernmental Agency

... vaccination 1988: before the global polio eradication initiative endemic non-endemic who. Global polio eradication initiative. Available at: http ...

Vaccine : Innovation and Technology Trends

  • Industry report
  • March 2014
  • 13 pages
  • by Intergovernmental Agency

Drug Market Analysis

4 months ago

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.